Comparative effects of antihypertensive therapy modes on the wall rigidity of various blood vessels

Дроботя, Н. В.; Гусейнова, Э. Ш.; Пироженко, А. А.

doi:10.18705/1607-419x-2016-22-2-217-226

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…В частности, при приеме 1 раз в день в дозе 4 мг он снижал артериальное давление на протяжении 24 ч с отношением остаточного эффекта к максимальному в пределах от 87 до 100 %; периндоприл уменьшал риск развития гипотонии после приема первой дозы, не снижал мозговой кровоток у лиц с острым ишемическим инсультом и обладал церебропротективным действием, нормализуя как функциональные, так и структурные изменения в крупных и мелких артериях. Таким образом, по данным этого исследования, пре па рат периндоприл был ре ко мен до ван для вто рич ной профи лак ти ки церебрального ин суль та [53,43].…”

unclassified

“…В недавно проведенном исследовании продемонстрировано статистически значимое снижение показателей жесткости сосудистой стенки различных отделов сосудистого русла -аорты, крупных и периферических артерий -на фоне терапии комбинацией периндоприла с индапамидом [53]. По мнению исследователей, целесообразно использовать данную комбинацию для обеспечения максимального вазопротективного эффекта [53]. Нефро-и церебропротективные эффекты периндоприла были подтверждены в исследовании И. В. Логачевой и соавт.…”

unclassified

See 1 more Smart Citation

Role of angiotensin-converting enzyme inhibitors in reducing cardiovascular and cerebral complications in chronic kidney disease: focus perindopril

Муркамилов

2021

Klinicist

View full text Add to dashboard Cite

In the development of renocardial relationships in chronic kidney disease, an important role is given to the activation of the renin-angiotensin-aldosterone system (RAAS), as the main component of the progression and development of cardiovascular complications..The presented review is devoted to the analysis of modern scientific data on the effect of high RAAS activity in chronic kidney disease on the course and prognosis of cardiovascular complications, as well as the protective capabilities of angiotensin-converting enzyme inhibitors, in particular perindopril. The results of scientific research on the role of the RAAS in the progression of chronic kidney disease are summarized. Data on chronic kidney disease as a risk factor for cardiovascular and cerebral complications are presented. Attention is focused on the possibilities of prolonging the pre-dialysis period of chronic kidney disease when using angiotensin-converting enzyme inhibitors. The role of perindopril as a lipophilic angiotensin-converting enzyme inhibitor with a high affinity for tissue RAAS was emphasized in reducing cardiovascular and cerebral risk in chronic kidney disease.

show abstract

unclassified

Role of angiotensin-converting enzyme inhibitors in reducing cardiovascular and cerebral complications in chronic kidney disease: focus perindopril

Муркамилов

2021

Klinicist

View full text Add to dashboard Cite

show abstract

Vessel rigidity, methods of its determination and practical importance in the work of a paramedic

2021

View full text Add to dashboard Cite

Important in the pathogenesis of many diseases of the cardiovascular system plays a decrease in elasticity and stiffening of the large arteries. Currently, one of the leading places is devoted to the study of the role of the vascular wall in the pathogenesis of hypertension. A number of studies indicate that an increase in the rigidity of the arterial bed is an independent factor of cardiovascular risk: at the same time, the risk of coronary artery disease, stroke, dissecting aortic aneurysms, and overall mortality from cardiovascular diseases is higher.

show abstract

Modern methods for determining and risk factors for the development of arterial stiffness in the practice of family medicine

Скворцов

Shevchenko

Malyakin

et al. 2021

Spravočnik Vrača Obŝej Praktiki (Journal of Family Medicine)

View full text Add to dashboard Cite

Vascular stiffness is an independent prognostic parameter for the development of cardiac pathology and cardiovascular mortality. The predictive value is high at the preclinical stages of the development of the disease, since blood vessels are an integral marker of cardiovascular pathology, through which classic risk factors for cardiovascular diseases (CVD) are realized. Vascular stiffness increases due to cholesterol deposits and calcification of the vessel wall. On the other hand, an increase in blood pressure (BP) causes changes in the vascular wall, including with the development of arteriolosclerosis, which can also lead to an increase in vascular stiffness.

show abstract

Comparative effects of antihypertensive therapy modes on the wall rigidity of various blood vessels

Cited by 3 publications

References 0 publications

Role of angiotensin-converting enzyme inhibitors in reducing cardiovascular and cerebral complications in chronic kidney disease: focus perindopril

Role of angiotensin-converting enzyme inhibitors in reducing cardiovascular and cerebral complications in chronic kidney disease: focus perindopril

Vessel rigidity, methods of its determination and practical importance in the work of a paramedic

Modern methods for determining and risk factors for the development of arterial stiffness in the practice of family medicine

Contact Info

Product

Resources

About